Skip to main content

Cancer_Epidemiology_Research_Program News

Study finds a role for AI in drug repurposing pipeline

A research team led by Wei-Qi Wei, MD, PhD, reported their findings on February 26th in Nature Digital Medicine. Their study searched for new treatments for Alzheimer’s disease (AD) by asking ChatGPT whether any existing drugs used for other problems might help patients with AD. ChatGPT is a cloud-based artificial intelligence program, a so-called large language model that’s been optimized for chat.

Monday, February 26th, 2024
After 40 years, genetics still surprises VUMC’s Nancy Cox

As she looks back on her 40-plus year career, what surprises Nancy Cox, PhD, an internationally known geneticist at Vanderbilt University Medical Center, is how much progress has been made, and yet how much more there is to learn about the role genetic variation plays in human disease.

Friday, November 10th, 2023
Research fellowship for genetic counselors established at Vanderbilt

Vanderbilt University School of Medicine has received a grant to establish a research fellowship for genetic counselors that will prepare them to contribute more fully to the advancement of personalized medicine.

Tuesday, October 3rd, 2023
Study finds new genetic susceptibilities for colon cancer

Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer.

Tuesday, September 12th, 2023
New reference tool supports replication of DNA biobank studies
Vanderbilt researchers created a phenotype-genotype reference map to assess data quality in DNA biobanks.
Thursday, August 31st, 2023
New leaders named to Vanderbilt-Ingram research programs

Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center's research programs.

Thursday, August 10th, 2023
Nancy Cox receives American Society of Human Genetics Leadership Award

Nancy Cox PhD director of the Vanderbilt Genetics Institute is the recipient of the 2023 ASHG Leadership Award from the American Society of Human Genetics.

Wednesday, July 26th, 2023
Holowatyj receives National Cancer Institute MERIT Award

Vanderbilt's Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute's Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health.

Wednesday, July 19th, 2023
Paul Harris named Vice President for Research Informatics

Paul Harris, PhD, has been appointed to a new role as Vice President for Research Informatics at Vanderbilt University Medical Center.

Tuesday, June 27th, 2023
Research identifies new target that may prevent blood cancer Research identifies new target that may prevent blood cancer

An international coalition of biomedical researchers co-led by Vanderbilts Alexander Bick MD PhD has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients risk of blood cancer.

Wednesday, April 12th, 2023
Wei Zheng Study incorporates genetics with smoking history to identify high-risk smokers for lung cancer screening
A study by Vanderbilt researchers that analyzed both smoking history and genetic risk variants for lung cancer supports modifying current guidelines to include additional smokers for lung cancer screening.
Tuesday, March 9th, 2021
Peterson tapped to direct VUMC’s Center for Precision Medicine Peterson tapped to direct VUMC’s Center for Precision Medicine
Josh Peterson, MD, MPH, professor of Biomedical Informatics and Medicine, has been named director of the Center for Precision Medicine at Vanderbilt University Medical Center, effective since Oct. 1.
Wednesday, November 18th, 2020
Breast cancer treatment in older women Breast cancer treatment in older women
Breast-conserving surgery (BCS) plus radiotherapy is the standard-of-care for women diagnosed with early-stage breast cancer.
Thursday, November 12th, 2020
Screening younger women for hereditary cancers may be cost effective Screening younger women for hereditary cancers may be cost effective
Population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost effective in women between the ages of 20 and 35, according to a study published in JAMA Network Open.
Thursday, November 5th, 2020
Variety of influences helped shape Birch’s medical career Variety of influences helped shape Birch’s medical career
Andrea Birch was 9 years old and on top of the world.
Thursday, October 22nd, 2020
3d rendered illustration of blood cells with droplets HDL-cholesterol and breast cancer risk
Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy.
Friday, January 24th, 2020
cancer in genetic code Study finds breast cancer recurrence score has different implications for men
A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer
Monday, December 23rd, 2019
yogurt High fiber, yogurt diet associated with lower lung cancer risk
A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers.
Monday, October 28th, 2019
Xiao Ou Shu Study finds men have higher mortality rate after breast cancer diagnosis
A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.
Thursday, October 17th, 2019
medical samples Potential prostate cancer biomarkers
An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.
Thursday, September 19th, 2019
African American patient with doctor Health disparity for blacks exists within lung screening guidelines
The U.S. Preventive Services Task Force (USPSTF) guidelines that determine which smokers qualify for CT scans exclude significant numbers of African Americans who develop lung cancer, a health disparity that merits modifications to lung cancer screening criteria, according to a study from Vanderbilt researchers.
Saturday, June 29th, 2019